MANILA, Philippines — 15 more patients of COVID-19 joined the World Health Organization’s (WHO) Solidarity Trial for a possible cure for the respiratory disease.
According to Health Secretary Maria Vergeire, Friday, May 8, the country now has 55 patients spread out in 10 hospitals in Metro Manila who are participating in the trial.
“Now is the 16th day of the trial and we have 55 patients enrolled in 10 hospitals in the National Capital Region (NCR),” she told reporters in an online press conference.
The Philippines was approved to participate in the activity by the Single Joint Research Ethics Board last April 17.
The study will test the effectiveness of possible treatments for COVID-19.
WHO and other 100 participating countries will compare the effectiveness of several drugs used in COVID-19 treatment in different countries.
Four different drugs or combinations will be tested, including remdesivir, lopinavir-ritonavir, lopinavir-ritonavir plus interferon beta, and chloroquine.